Cargando…

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

AIM: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. METHODS & MATERIALS: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies reporting our pre-specified outcomes. RESULT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memon, Areeba, Larik, Muhammad Omar, Khan, Zoha, Urooj, Maryam, Irfan, Areeka, Kumari, Beena, Faisal, Mehak, Siddiqui, Rida, Tehrim, Moniba, Hameed, Ishaque
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2023
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518811/ https://www.ncbi.nlm.nih.gov/pubmed/37753355 http://dx.doi.org/10.2144/fsoa-2023-0059

Ejemplares similares

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
por: Dong, Tiffany, et al.
Publicado: (2023)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review
por: Edelberg, Jay M., et al.
Publicado: (2022)

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten
por: Mathai, Susan, et al.
Publicado: (2022)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis
por: Christian, Susan, et al.
Publicado: (2022)

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
por: DeVries, J Hans, et al.
Publicado: (2023)

Considerations for managed care pharmacy in evaluating mavacamten, a novel agent for obstructive hypertrophic cardiomyopathy
por: Taddei-Allen, Patty
Publicado: (2022)

Treatment with Testosterone Therapy in Type 2 Diabetic Hypogonadal Adult Males: A Systematic Review and Meta-Analysis
por: Kumari, Kajol, et al.
Publicado: (2023)

Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
por: Tian, Zhuang, et al.
Publicado: (2023)

Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials
por: Rabiee Rad, Mehrdad, et al.
Publicado: (2023)

Analyzing safety and effectiveness of Mavacamten in comparison with placebo for managing hypertrophic cardiomyopathy: a systemic review and meta-analysis
por: Rangwala, Hussain Sohail, et al.
Publicado: (2023)

Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM)
por: Langley, Paul C
Publicado: (2022)

Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment
por: Wang, Kai, et al.
Publicado: (2023)

Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis
por: Bi, Minglei, et al.
Publicado: (2019)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca(2+) flux caused by thin filament hypertrophic cardiomyopathy mutations
por: Sparrow, Alexander J., et al.
Publicado: (2020)

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Beinfeld, Molly, et al.
Publicado: (2022)

Mavacamten: First Approval
por: Keam, Susan J.
Publicado: (2022)

Risk factors for actinic cheilitis: A meta-analysis
por: Rodriguez-Archilla, Alberto, et al.
Publicado: (2021)

Correction to: Mavacamten: First Approval
por: Keam, Susan J.
Publicado: (2022)

Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review
por: Rebhun, Jeffrey, et al.
Publicado: (2023)

Effects of spinal mobilization techniques in the management of adolescent idiopathic scoliosis - A meta-analysis
por: Farooqui, Sumaira Imran, et al.
Publicado: (2018)

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β(2)-agonist fixed-dose combinations in COPD
por: Siddiqui, Mohd Kashif, et al.
Publicado: (2019)

Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis
por: Yassin, Ahmed, et al.
Publicado: (2021)

Does music reduce anxiety and discomfort during flexible sigmoidoscopy? A systematic review and meta-analysis
por: Shanmuganandan, Arun P, et al.
Publicado: (2017)

Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events
por: Mashiana, Harmeet Singh, et al.
Publicado: (2018)

A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer
por: Soh, Sheila X., et al.
Publicado: (2017)

Effects of omecamtiv mecarbil and mavacamten in isolated human atrium
por: Abella, Lina Maria Rayo, et al.
Publicado: (2022)

Systematic Review of Genotype‐Phenotype Correlations in Noncompaction Cardiomyopathy
por: van Waning, Jaap I., et al.
Publicado: (2019)

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
por: Liga, Riccardo, et al.
Publicado: (2023)

Invited Commentary: Is Monitoring of Human Papillomavirus Infection for Viral Persistence Ready for Use in Cervical Cancer Screening?
por: Castle, Philip E.
Publicado: (2008)

Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials
por: AbuMweis, Suhad S., et al.
Publicado: (2008)

Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials
por: Pripp, Are Hugo
Publicado: (2008)

A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia
por: Nickel, J C, et al.
Publicado: (2008)

How strong is the association between abdominal obesity and the incidence of type 2 diabetes?
por: Freemantle, N, et al.
Publicado: (2008)

Effect of Fructose on Glycemic Control in Diabetes: A systematic review and meta-analysis of controlled feeding trials
por: Cozma, Adrian I., et al.
Publicado: (2012)

Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
por: Vejakama, P., et al.
Publicado: (2011)

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1s5f6kjmitt1lli84b2e76k6fp